Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

What do we really know about antibiotic pharmacodynamics?

B W Gunderson1, G H Ross, K H Ibrahim

  • 1Department of Experimental and Clinical Pharmacology, University of Minnesota College of Pharmacy, Minneapolis 55455, USA.

Pharmacotherapy
|November 21, 2001
PubMed
Summary

Antibiotic pharmacodynamics links drug levels to bacterial killing and adverse effects. Understanding these relationships helps optimize antibiotic use, develop new drugs, and combat resistance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of pentoxifylline on tumor necrosis factor-alpha and interleukin-6 levels in neonatal sepsis.

The Medical journal of Malaysia·2005
Same author

Plasmid-mediated complementation of gyrA and gyrB in fluoroquinolone-resistant Bacteroides fragilis.

The Journal of antimicrobial chemotherapy·2003
Same author

In vitro pharmacodynamic analysis of single daily dosing versus conventional dosing of gentamicin administered with penicillin against Enterococcus faecalis.

Pharmacotherapy·2002
Same author

Pharmacodynamics of trovafloxacin and levofloxacin against Bacteroides fragilis in an in vitro pharmacodynamic model.

Antimicrobial agents and chemotherapy·2001
Same author

Compartmental pharmacokinetics and tissue distribution of the antifungal echinocandin lipopeptide micafungin (FK463) in rabbits.

Antimicrobial agents and chemotherapy·2001
Same author

Comparison of once-daily versus twice-daily administration of cefdinir against typical bacterial respiratory tract pathogens.

Antimicrobial agents and chemotherapy·2001

Area of Science:

  • Pharmacology
  • Microbiology
  • Infectious Diseases

Background:

  • Antibiotic pharmacodynamics investigates the relationship between drug concentration and antimicrobial effects, including bacterial death and adverse reactions.
  • Antibiotic actions are classified as concentration-dependent or independent, varying by drug and pathogen.
  • Quantitative parameters like AUC0-24:MIC, Cmax:MIC, and T>MIC are explored as predictors of treatment outcomes.

Purpose of the Study:

  • To review the current state and future potential of antibiotic pharmacodynamics.
  • To highlight the role of pharmacodynamics in antibiotic development, clinical decision-making, and resistance management.

Main Methods:

  • Review of existing literature on antibiotic pharmacodynamics.
  • Analysis of various quantitative pharmacodynamic parameters (AUC0-24:MIC, Cmax:MIC, T>MIC).

Related Experiment Videos

  • Synthesis of in vitro, animal, and human data.

    • Main Results:

    • Pharmacodynamic principles are applicable across various antibiotic classes, including fluoroquinolones, vancomycin, beta-lactams, macrolides, and aminoglycosides.
    • Existing pharmacodynamic modeling systems show agreement across different data types.
    • Pharmacodynamic parameters show promise in predicting clinical and microbiologic success.

    Conclusions:

    • Antibiotic pharmacodynamics is a valuable tool for developing new antibiotics efficiently.
    • Pharmacodynamic parameters can aid formulary committees in antibiotic selection.
    • These principles can guide optimal dosing strategies for severe infections and potentially limit antibiotic resistance.
    • Antibiotic pharmacodynamics is poised to become a routine aspect of clinical practice.